Natural anti-A and anti-B of the ABO system: allo- and autoantibodies have different epitope specificity

• Published in: Transfusion (Philadelphia, Pa.) Pa.), 2012-04, Vol.52 (4), p.860-869
• Main Authors: Obukhova, Polina, Korchagina, Elena, Henry, Stephen, Bovin, Nicolai
• Format: Article
• Language: English
• Subjects: ABO Blood-Group System - immunology; ABO system; Adult; Alloantibodies; Autoantibodies; Autoantibodies - immunology; Autoantibodies - isolation & purification; Blood group A; Blood groups; Carbohydrates; Chromatography; Disaccharides; Epitopes; fucose; glycoconjugates; Humans; Immunoglobulin G; Isoantibodies - immunology; Isoantibodies - isolation & purification; Lymphocytes B; Polysaccharides - metabolism; Sugar
• ISSN: 0041-1132; 1537-2995
• DOI: 10.1111/j.1537-2995.2011.03381.x

BACKGROUND: According to Landsteiner's law, alloantibodies are prevalent and autoantibodies are absent in the ABO blood group system. However, one study (Spalter et al., Blood 1999;93:4418‐24) has suggested that low‐affinity ABO autoantibodies, mitigated by anti‐idiotypic immunoglobulins are also prevalent, while another publication (Rieben et al., Eur J Immunol 1992;22:2713‐7) shows that humans do not have B‐lymphocytes capable of producing immunoglobulin G ABO autoantibodies. STUDY DESIGN AND METHODS: We used hapten‐specific chromatography to isolate allo‐ and autoantibodies from pools of A or B serum and then characterized the resultant antibodies against a wide range of ABO and related glycoconjugates. RESULTS: We found that the apparent autoantibodies are directed against blood group A or B disaccharides, without consideration for the presence of fucose, but requiring the absence of elongating sugar X in composition of Gal(NAc)α1‐3(Fucα1‐2)Galβ1‐X–terminated carbohydrate chain. In contrast, ABO alloantibodies required a minimum trisaccharide Gal(NAc)α1‐3(Fucα1‐2)Gal epitope and recognize the elongated type‐specific tetrasaccharides. Furthermore, alloantibodies appear to be a small set of specific yet crossreactive antibodies that detect all backbone types of A or B antigens, rather than being a collection of specific antibodies, each of which detects a different type of A or B antigen. CONCLUSION: Apparent ABO autoantibodies appear to have no natural human target.